Anti-FOXP3 antibody (ab10563)

ab10563 has been referenced in 19 publications.

1. Kosmidis M et al. Immunosuppression affects CD4+ mRNA expression and induces Th2 dominance in the microenvironment of cutaneous squamous cell carcinoma in organ transplant recipients. J Immunother 33:538-46 (2010). IHC-P; Human. PubMed: 20463594
2. Chen YT et al. Interleukin-1 as a Phenotypic Immunomodulator in Keratinizing Squamous Metaplasia of the Ocular Surface in Sjogren's Syndrome. Am J Pathol 177:1333-43 (2010). IHC-P. PubMed: 20696775
3. Hansenne I et al. Aire and Foxp3 expression in a particular microenvironment for T cell differentiation. Neuroimmunomodulation 16:35-44 (2009). ICC/IF. PubMed: 19077444
4. Graciolli FG et al. Phosphorus overload and PTH induce aortic expression of Runx2 in experimental uraemia. Nephrol Dial Transplant 24:1416-21 (2009). PubMed: 19075196
5. Mühleisen B et al. Progression of cutaneous squamous cell carcinoma in immunosuppressed patients is associated with reduced CD123+ and FOXP3+ cells in the perineoplastic inflammatory infiltrate. Histopathology 55:67-76 (2009). IHC-P; Human. PubMed: 19614769
6. Plumb J et al. Increased T-regulatory cells within lymphocyte follicles in moderate COPD. Eur Respir J 34:89-94 (2009). IHC-P; Human. PubMed: 19196820
7. Ghebeh H et al. FOXP3+ Tregs and B7-H1+/PD-1+ T lymphocytes co-infiltrate the tumor tissues of high-risk breast cancer patients: Implication for immunotherapy. BMC Cancer 8:57 (2008). IHC-Fr; Human. PubMed: 18294387
8. Tzartos JS et al. Interleukin-17 production in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosis. Am J Pathol 172:146-55 (2008). IHC-Fr; Human. PubMed: 18156204
9. Ebert LM et al. The regulatory T cell-associated transcription factor FoxP3 is expressed by tumor cells. Cancer Res 68:3001-9 (2008). IHC-P; Human. PubMed: 18413770
10. Van Bruaene N et al. T-cell regulation in chronic paranasal sinus disease. J Allergy Clin Immunol 121:1435-41, 1441.e1-3 (2008). PubMed: 18423831
11. Mantel PY et al. GATA3-driven Th2 responses inhibit TGF-beta1-induced FOXP3 expression and the formation of regulatory T cells. PLoS Biol 5:e329 (2007). WB; Human. PubMed: 18162042
12. Gansuvd B et al. Expansion of CD4+CD25+ suppressive regulatory T cells from rhesus macaque peripheral blood by FN18/antihuman CD28-coated Dynal beads. Hum Immunol 68:478-90 (2007). PubMed: 17509447
13. Deng W et al. The lysophosphatidic acid type 2 receptor is required for protection against radiation-induced intestinal injury. Gastroenterology 132:1834-51 (2007). PubMed: 17484878
14. Xu Q et al. Human CD4+CD25low adaptive T regulatory cells suppress delayed-type hypersensitivity during transplant tolerance. J Immunol 178:3983-95 (2007). PubMed: 17339499
15. Siddiqui SA et al. Tumor-infiltrating Foxp3-CD4+CD25+ T cells predict poor survival in renal cell carcinoma. Clin Cancer Res 13:2075-81 (2007). IHC-Fr; Human. PubMed: 17404089
16. Verhagen J et al. Absence of T-regulatory cell expression and function in atopic dermatitis skin. J Allergy Clin Immunol 117:176-83 (2006). PubMed: 16387603
17. Heller EA et al. Chemokine CXCL10 promotes atherogenesis by modulating the local balance of effector and regulatory T cells. Circulation 113:2301-12 (2006). PubMed: 16682613
18. Grant C et al. Foxp3 represses retroviral transcription by targeting both NF-kappaB and CREB pathways. PLoS Pathog 2:e33 (2006). PubMed: 16652169
19. Bovenschen HJ et al. Identification of lesional CD4+ CD25+ Foxp3+ regulatory T cells in Psoriasis. Dermatology 213:111-7 (2006). PubMed: 16902287